Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy

D. A. Palay, P. Sternberg, Janet L Davis, H. Lewis, G. N. Holland, W. F. Mieler, D. A. Jabs, C. Drews

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

We reviewed the course of 54 patients who had unilateral acute retinal necrosis at initial examination. Thirty-one patients were treated with acyclovir, whereas 23 were not. Of the 31 patients treated with acyclovir, 27 (87.1%) had fellow eyes that remained disease-free throughout a median follow-up of 12 months. Of the 23 patients not treated with acyclovir, seven (30.4%) had fellow eyes that remained disease-free throughout a median follow-up of 11 months. Survival analysis indicated that the fellow eyes of the group of patients treated with acyclovir were more likely to remain disease-free than the fellow eyes of the group not treated with acyclovir (P = .0013). Two years after initial onset, the proportion of fellow eyes that remained disease-free was 75.3% for the group treated with acyclovir and 35.1% for the group not treated with acyclovir. These results suggest that acyclovir treatment reduces the risk of involvement of the fellow eye in patients with acute retinal necrosis.

Original languageEnglish
Pages (from-to)250-255
Number of pages6
JournalAmerican Journal of Ophthalmology
Volume112
Issue number3
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Acute Retinal Necrosis Syndrome
Acyclovir
Eye Diseases
Therapeutics
Survival Analysis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Palay, D. A., Sternberg, P., Davis, J. L., Lewis, H., Holland, G. N., Mieler, W. F., ... Drews, C. (1991). Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. American Journal of Ophthalmology, 112(3), 250-255.

Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. / Palay, D. A.; Sternberg, P.; Davis, Janet L; Lewis, H.; Holland, G. N.; Mieler, W. F.; Jabs, D. A.; Drews, C.

In: American Journal of Ophthalmology, Vol. 112, No. 3, 01.01.1991, p. 250-255.

Research output: Contribution to journalArticle

Palay, DA, Sternberg, P, Davis, JL, Lewis, H, Holland, GN, Mieler, WF, Jabs, DA & Drews, C 1991, 'Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy', American Journal of Ophthalmology, vol. 112, no. 3, pp. 250-255.
Palay DA, Sternberg P, Davis JL, Lewis H, Holland GN, Mieler WF et al. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. American Journal of Ophthalmology. 1991 Jan 1;112(3):250-255.
Palay, D. A. ; Sternberg, P. ; Davis, Janet L ; Lewis, H. ; Holland, G. N. ; Mieler, W. F. ; Jabs, D. A. ; Drews, C. / Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. In: American Journal of Ophthalmology. 1991 ; Vol. 112, No. 3. pp. 250-255.
@article{b4f832d9be8c4cf291441da75ed0f7f4,
title = "Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy",
abstract = "We reviewed the course of 54 patients who had unilateral acute retinal necrosis at initial examination. Thirty-one patients were treated with acyclovir, whereas 23 were not. Of the 31 patients treated with acyclovir, 27 (87.1{\%}) had fellow eyes that remained disease-free throughout a median follow-up of 12 months. Of the 23 patients not treated with acyclovir, seven (30.4{\%}) had fellow eyes that remained disease-free throughout a median follow-up of 11 months. Survival analysis indicated that the fellow eyes of the group of patients treated with acyclovir were more likely to remain disease-free than the fellow eyes of the group not treated with acyclovir (P = .0013). Two years after initial onset, the proportion of fellow eyes that remained disease-free was 75.3{\%} for the group treated with acyclovir and 35.1{\%} for the group not treated with acyclovir. These results suggest that acyclovir treatment reduces the risk of involvement of the fellow eye in patients with acute retinal necrosis.",
author = "Palay, {D. A.} and P. Sternberg and Davis, {Janet L} and H. Lewis and Holland, {G. N.} and Mieler, {W. F.} and Jabs, {D. A.} and C. Drews",
year = "1991",
month = "1",
day = "1",
language = "English",
volume = "112",
pages = "250--255",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy

AU - Palay, D. A.

AU - Sternberg, P.

AU - Davis, Janet L

AU - Lewis, H.

AU - Holland, G. N.

AU - Mieler, W. F.

AU - Jabs, D. A.

AU - Drews, C.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - We reviewed the course of 54 patients who had unilateral acute retinal necrosis at initial examination. Thirty-one patients were treated with acyclovir, whereas 23 were not. Of the 31 patients treated with acyclovir, 27 (87.1%) had fellow eyes that remained disease-free throughout a median follow-up of 12 months. Of the 23 patients not treated with acyclovir, seven (30.4%) had fellow eyes that remained disease-free throughout a median follow-up of 11 months. Survival analysis indicated that the fellow eyes of the group of patients treated with acyclovir were more likely to remain disease-free than the fellow eyes of the group not treated with acyclovir (P = .0013). Two years after initial onset, the proportion of fellow eyes that remained disease-free was 75.3% for the group treated with acyclovir and 35.1% for the group not treated with acyclovir. These results suggest that acyclovir treatment reduces the risk of involvement of the fellow eye in patients with acute retinal necrosis.

AB - We reviewed the course of 54 patients who had unilateral acute retinal necrosis at initial examination. Thirty-one patients were treated with acyclovir, whereas 23 were not. Of the 31 patients treated with acyclovir, 27 (87.1%) had fellow eyes that remained disease-free throughout a median follow-up of 12 months. Of the 23 patients not treated with acyclovir, seven (30.4%) had fellow eyes that remained disease-free throughout a median follow-up of 11 months. Survival analysis indicated that the fellow eyes of the group of patients treated with acyclovir were more likely to remain disease-free than the fellow eyes of the group not treated with acyclovir (P = .0013). Two years after initial onset, the proportion of fellow eyes that remained disease-free was 75.3% for the group treated with acyclovir and 35.1% for the group not treated with acyclovir. These results suggest that acyclovir treatment reduces the risk of involvement of the fellow eye in patients with acute retinal necrosis.

UR - http://www.scopus.com/inward/record.url?scp=0025914993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025914993&partnerID=8YFLogxK

M3 - Article

C2 - 1882936

AN - SCOPUS:0025914993

VL - 112

SP - 250

EP - 255

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 3

ER -